De Giorgis V - Search Results

1

The Need for Biomarkers in the ALS-FTD Spectrum: A Clinical Point of View on the Role of Proteomics.

Vignaroli F, Mele A, Tondo G, De Giorgis V, Manfredi M, Comi C, Mazzini L, De Marchi F. Vignaroli F, et al. Among authors: de giorgis v, de marchi f. Proteomes. 2023 Jan 9;11(1):1. doi: 10.3390/proteomes11010001. Proteomes. 2023. PMID: 36648959 Free PMC article. Review.

2

Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection.

Barberis E, Vanella VV, Falasca M, Caneapero V, Cappellano G, Raineri D, Ghirimoldi M, De Giorgis V, Puricelli C, Vaschetto R, Sainaghi PP, Bruno S, Sica A, Dianzani U, Rolla R, Chiocchetti A, Cantaluppi V, Baldanzi G, Marengo E, Manfredi M. Barberis E, et al. Among authors: de giorgis v. Front Mol Biosci. 2021 Feb 22;8:632290. doi: 10.3389/fmolb.2021.632290. eCollection 2021. Front Mol Biosci. 2021. PMID: 33693030 Free PMC article.

3

Tumor Suppressor Role of Wild-Type P53-Dependent Secretome and Its Proteomic Identification in PDAC.

Butera G, Manfredi M, Fiore A, Brandi J, Pacchiana R, De Giorgis V, Barberis E, Vanella V, Galasso M, Scupoli MT, Marengo E, Cecconi D, Donadelli M. Butera G, et al. Among authors: de giorgis v. Biomolecules. 2022 Feb 13;12(2):305. doi: 10.3390/biom12020305. Biomolecules. 2022. PMID: 35204804 Free PMC article.

4

In-Depth Proteomic Analysis of Blood Circulating Small Extracellular Vesicles.

De Giorgis V, Barberis E, Falasca M, Manfredi M. De Giorgis V, et al. Methods Mol Biol. 2023;2628:279-289. doi: 10.1007/978-1-0716-2978-9_18. Methods Mol Biol. 2023. PMID: 36781792

5

The Pro-Oncogenic Sphingolipid-Metabolizing Enzyme β-Galactosylceramidase Modulates the Proteomic Landscape in BRAF(V600E)-Mutated Human Melanoma Cells.

Capoferri D, Chiodelli P, Corli M, Belleri M, Scalvini E, Mignani L, Guerra J, Grillo E, De Giorgis V, Manfredi M, Presta M. Capoferri D, et al. Among authors: de giorgis v. Int J Mol Sci. 2023 Jun 23;24(13):10555. doi: 10.3390/ijms241310555. Int J Mol Sci. 2023. PMID: 37445731 Free PMC article.

6

Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitness.

Monti M, Benerini Gatta L, Bugatti M, Pezzali I, Picinoli S, Manfredi M, Lavazza A, Vanella VV, De Giorgis V, Zanatta L, Missale F, Lonardi S, Zanetti B, Bozzoni G, Cadei M, Abate A, Vergani B, Balzarini P, Battocchio S, Facco C, Turri-Zanoni M, Castelnuovo P, Nicolai P, Fonsatti E, Leone BE, Marengo E, Sigala S, Ronca R, Perego M, Lombardi D, Vermi W. Monti M, et al. Among authors: de giorgis v. J Transl Med. 2024 Jan 8;22(1):35. doi: 10.1186/s12967-023-04784-2. J Transl Med. 2024. PMID: 38191367 Free PMC article.

7

CD99 Modulates the Proteomic Landscape of Ewing Sarcoma Cells and Related Extracellular Vesicles.

De Feo A, Manfredi M, Mancarella C, Maqueda JJ, De Giorgis V, Pignochino Y, Sciandra M, Cristalli C, Donadelli M, Scotlandi K. De Feo A, et al. Among authors: de giorgis v. Int J Mol Sci. 2024 Jan 27;25(3):1588. doi: 10.3390/ijms25031588. Int J Mol Sci. 2024. PMID: 38338867 Free PMC article.

8

Astroglial calcium signaling and homeostasis in tuberous sclerosis complex.

Romagnolo A, Dematteis G, Scheper M, Luinenburg MJ, Mühlebner A, Van Hecke W, Manfredi M, De Giorgis V, Reano S, Filigheddu N, Bortolotto V, Tapella L, Anink JJ, François L, Dedeurwaerdere S, Mills JD, Genazzani AA, Lim D, Aronica E. Romagnolo A, et al. Among authors: de giorgis v. Acta Neuropathol. 2024 Feb 28;147(1):48. doi: 10.1007/s00401-024-02711-3. Acta Neuropathol. 2024. PMID: 38418708 Free PMC article.

9

Differential proteomics profile of microcapillary networks in response to sound pattern-driven local cell density enhancement.

Di Marzio N, Tognato R, Bella ED, De Giorgis V, Manfredi M, Cochis A, Alini M, Serra T. Di Marzio N, et al. Among authors: de giorgis v. Biomater Biosyst. 2024 Mar 29;14:100094. doi: 10.1016/j.bbiosy.2024.100094. eCollection 2024 Jun. Biomater Biosyst. 2024. PMID: 38596510 Free PMC article.

10

Triheptanoin Did Not Show Benefit versus Placebo for the Treatment of Paroxysmal Movement Disorders in Glut1 Deficiency Syndrome: Results of a Randomized Phase 3 Study.

De Giorgis V, Bhatia KP, Boespflug-Tanguy O, Gras D, Marina AD, Desurkar A, Toledo M, Miller I, Rotstein M, Schneider SA, Tarquinio DC, Weber Y, Brandabur M, Mayhew J, Koutsoukos T, De Vivo DC. De Giorgis V, et al. Mov Disord. 2024 May 9. doi: 10.1002/mds.29822. Online ahead of print. Mov Disord. 2024. PMID: 38725190

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

103 results

Search Page